Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-26-000033·Celldex Therapeutics, Inc.
Schedule 13G ownership disclosure
Celldex Therapeutics Inc
COMMON STOCK · CUSIP: 15117B202
Event date: 2025-12-31
- Filing-level shares
- 3,397,713.00
- Percent of class
- 5.1%
- STATE STREET CORPORATION
Shares: 3,397,713.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-26-000033
- Form type
- SCHEDULE 13G
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership